-
Je něco špatně v tomto záznamu ?
Cytochrome P450 and flavin-containing monooxygenase enzymes are responsible for differential oxidation of the anti-thyroid-cancer drug vandetanib by human and rat hepatic microsomal systems
R. Indra, P. Pompach, K. Vavrová, K. Jáklová, Z. Heger, V. Adam, T. Eckschlager, K. Kopečková, VM. Arlt, M. Stiborová,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- chinazoliny metabolismus MeSH
- jaterní mikrozomy MeSH
- krysa rodu rattus MeSH
- lidé MeSH
- oxidace-redukce MeSH
- oxygenasy metabolismus MeSH
- piperidiny metabolismus MeSH
- protinádorové látky metabolismus MeSH
- systém (enzymů) cytochromů P-450 metabolismus MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
We studied the in vitro metabolism of the anti-thyroid-cancer drug vandetanib in a rat animal model and demonstrated that N-desmethylvandetanib and vandetanib N-oxide are formed by NADPH- or NADH-mediated reactions catalyzed by rat hepatic microsomes and pure biotransformation enzymes. In addition to the structural characterization of vandetanib metabolites, individual rat enzymes [cytochrome P450 (CYP) and flavin-containing monooxygenase (FMO)] capable of oxidizing vandetanib were identified. Generation of N-desmethylvandetanib, but not that of vandetanib N-oxide, was attenuated by CYP3A and 2C inhibitors while inhibition of FMO decreased formation of vandetanib N-oxide. These results indicate that liver microsomal CYP2C/3A and FMO1 are major enzymes participating in the formation of N-desmethylvandetanib and vandetanib N-oxide, respectively. Rat recombinant CYP2C11 > >3A1 > 3A2 > 1A1 > 1A2 > 2D1 > 2D2 were effective in catalyzing the formation of N-desmethylvandetanib. Results of the present study explain differences between the CYP- and FMO-catalyzed vandetanib oxidation in rat and human liver reported previously and the enzymatic mechanisms underlying this phenomenon.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20025222
- 003
- CZ-PrNML
- 005
- 20201222160131.0
- 007
- ta
- 008
- 201125s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.etap.2019.103310 $2 doi
- 035 __
- $a (PubMed)31837525
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Indra, Radek $u Department of Biochemistry, Faculty of Science, Charles University, Albertov, 2030, 128 40 Prague 2, Czech Republic.
- 245 10
- $a Cytochrome P450 and flavin-containing monooxygenase enzymes are responsible for differential oxidation of the anti-thyroid-cancer drug vandetanib by human and rat hepatic microsomal systems / $c R. Indra, P. Pompach, K. Vavrová, K. Jáklová, Z. Heger, V. Adam, T. Eckschlager, K. Kopečková, VM. Arlt, M. Stiborová,
- 520 9_
- $a We studied the in vitro metabolism of the anti-thyroid-cancer drug vandetanib in a rat animal model and demonstrated that N-desmethylvandetanib and vandetanib N-oxide are formed by NADPH- or NADH-mediated reactions catalyzed by rat hepatic microsomes and pure biotransformation enzymes. In addition to the structural characterization of vandetanib metabolites, individual rat enzymes [cytochrome P450 (CYP) and flavin-containing monooxygenase (FMO)] capable of oxidizing vandetanib were identified. Generation of N-desmethylvandetanib, but not that of vandetanib N-oxide, was attenuated by CYP3A and 2C inhibitors while inhibition of FMO decreased formation of vandetanib N-oxide. These results indicate that liver microsomal CYP2C/3A and FMO1 are major enzymes participating in the formation of N-desmethylvandetanib and vandetanib N-oxide, respectively. Rat recombinant CYP2C11 > >3A1 > 3A2 > 1A1 > 1A2 > 2D1 > 2D2 were effective in catalyzing the formation of N-desmethylvandetanib. Results of the present study explain differences between the CYP- and FMO-catalyzed vandetanib oxidation in rat and human liver reported previously and the enzymatic mechanisms underlying this phenomenon.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x metabolismus $7 D000970
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a jaterní mikrozomy $7 D008862
- 650 _2
- $a oxidace-redukce $7 D010084
- 650 _2
- $a oxygenasy $x metabolismus $7 D010105
- 650 _2
- $a piperidiny $x metabolismus $7 D010880
- 650 _2
- $a chinazoliny $x metabolismus $7 D011799
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Pompach, Petr $u Department of Biochemistry, Faculty of Science, Charles University, Albertov, 2030, 128 40 Prague 2, Czech Republic.
- 700 1_
- $a Vavrová, Katarína $u Department of Biochemistry, Faculty of Science, Charles University, Albertov, 2030, 128 40 Prague 2, Czech Republic.
- 700 1_
- $a Jáklová, Kateřina $u Department of Biochemistry, Faculty of Science, Charles University, Albertov, 2030, 128 40 Prague 2, Czech Republic.
- 700 1_
- $a Heger, Zbyněk $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, 61300 Brno, Czech Republic.
- 700 1_
- $a Adam, Vojtěch $u Department of Chemistry and Biochemistry, Mendel University in Brno, Zemedelska 1, 61300 Brno, Czech Republic.
- 700 1_
- $a Eckschlager, Tomáš $u Department of Pediatric Hematology and Oncology, 2nd Medical Faculty, Charles University and University Hospital Motol, 150 06 Prague, Czech Republic.
- 700 1_
- $a Kopečková, Kateřina $u Department of Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, 150 06 Prague 5, Czech Republic.
- 700 1_
- $a Arlt, Volker Manfred $u Department of Analytical, Environmental and Forensic Sciences, MRC-PHE Centre for Environment and Health, King's College London, 150 Stamford Street, London SE1 9NH, United Kingdom.
- 700 1_
- $a Stiborová, Marie $u Department of Biochemistry, Faculty of Science, Charles University, Albertov, 2030, 128 40 Prague 2, Czech Republic. Electronic address: stiborov@natur.cuni.cz.
- 773 0_
- $w MED00008557 $t Environmental toxicology and pharmacology $x 1872-7077 $g Roč. 74, č. - (2020), s. 103310
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31837525 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201125 $b ABA008
- 991 __
- $a 20201222160127 $b ABA008
- 999 __
- $a ok $b bmc $g 1599367 $s 1115908
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 74 $c - $d 103310 $e 20191203 $i 1872-7077 $m Environmental toxicology and pharmacology $n Environ. toxicol. pharmacol. $x MED00008557
- LZP __
- $a Pubmed-20201125
